« Previous
Next »
Fertility and Sterility
Volume 91, Issue 5
, Pages
1654-1656
, May 2009
Return to fertility after cessation of a continuous oral contraceptive
To access this article, please choose from the options below
Supported by a grant from Wyeth Research, Collegeville, Pa.
K.B. was an investigator for this poststudy follow-up and received research funding from Wyeth Research, Collegeville, Pa. Other sources of research funding and/or financial relationships include Novo Nordisk (consultant), Organon (speaker and investigator), Johnson & Johnson, Duramed, Xanodyne, Boehringer Ingelheim, Third Wave, Pfizer, and MGI Pharma (investigator). S.M., G.G., and G.C. are employees of Wyeth Research. Other financial affiliation for G.G. is Johnson & Johnson. S.M. and G.C. have no other financial affiliation to disclose.
PII: S0015-0282(08)00484-6
doi: 10.1016/j.fertnstert.2008.02.122
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 91, Issue 5
, Pages
1654-1656
, May 2009

